Helen Tayton-Martin

Helen Tayton-Martin

Company: Adaptimmune

Job title: CBO


The Road to Commercialization: Preparing for BLA, Commercial Readiness, Upscaling Manufacturing for the First Commercial TCR-T Cell Therapy 9:30 am

• Regulatory challenges for an autologous TCR-T cell therapy and companion diagnostics • Creating a commercial infrastructure to enter a field where prescribers and payers have limited cell therapy experience in solid tumors • Manufacturing challenges for a product ready for a franchiseRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.